Daytrana | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Daytrana
Canada

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Daytrana

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 20 USDMF, 15 CEP/COS, 1 JDMF, 6 EU WC, 8 KDMF, 22 NDC API, 17 Listed Suppliers, $ API Reference Price

36 API Suppliers
20 USDMF
15 CEP/COS
1 JDMF
6 EU WC
8 KDMF
22 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

608 FDF Dossiers, 262 FDA Orange Book, 232 Europe, 52 Canada, 30 South Africa, 32 Listed Dossiers

608 FDF Dossiers
262 FDA Orange Book
232 Europe
52 Canada
30 South Africa
32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 18MG, TABLET, EXTENDED RELEASE;ORAL - 27MG, TABLET, EXTENDED RELEASE;ORAL - 36MG, TABLET, EXTENDED RELEASE;ORAL - 54MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 5MG
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 15MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 18MG
TABLET, EXTENDED RELEASE;ORAL - 27MG
TABLET, EXTENDED RELEASE;ORAL - 36MG
TABLET, EXTENDED RELEASE;ORAL - 54MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
SOLUTION;ORAL - 10MG/5ML
SOLUTION;ORAL - 5MG/5ML
TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 8 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 18 DKSH, 1 Jai Radhe Sales, 2 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 20 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 2 Hayashibara, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 36 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 6 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

112 Fillers, Diluents & Binders, 84 Coating Systems & Additives, 54 Controlled & Modified Release, 50 Thickeners and Stabilizers, 46 Direct Compression, 37 Taste Masking, 32 Solubilizers, 30 Film Formers & Plasticizers, 30 Granulation, 28 Disintegrants & Superdisintegrants, 27 Topical, 27 Parenteral, 27 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

112 Fillers, Diluents & Binders
84 Coating Systems & Additives
54 Controlled & Modified Release
50 Thickeners and Stabilizers
46 Direct Compression
37 Taste Masking
32 Solubilizers
30 Film Formers & Plasticizers
30 Granulation
28 Disintegrants & Superdisintegrants
27 Topical
27 Parenteral
27 Lubricants & Glidants
22 Chewable & Orodispersible Aids
19 Co-Processed Excipients
10 Emulsifying Agents
9 Empty Capsules
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 70 NEWS #PharmaBuzz

6 DATA COMPILATION #PharmaFlow
70 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 150 Finished Drug Prices, 2 Annual Reports

9 US Medicaid Prescriptions
150 Finished Drug Prices
2 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

10 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

191 US Patents, 6 US Exclusivities, 25 Health Canada Patents

191 US Patents
6 US Exclusivities
25 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 Others

3 EDQM
2 USP
3 Others

$ API Ref.Price (USD/KG) : 690 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

52 All

01 8APOTEX INC

02 15ELVIUM LIFE SCIENCES

03 4JANSSEN INC

04 3KYE PHARMACEUTICALS INC.

05 11PHARMASCIENCE INC

06 7Pharmascience Inc.

07 4TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

52 All

01 45METHYLPHENIDATE HYDROCHLORIDE

02 7Methylphenidate Hydrochloride

filter Dosage Form Reset all filters

52 All

01 7CAPSULE (CONTROLLED RELEASE)

02 16CAPSULE (EXTENDED RELEASE)

03 9TABLET

04 3TABLET (CHEWABLE, EXTENDED-RELEASE)

05 17TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

52 All

01 4ACT METHYLPHENIDATE ER

02 3APO-METHYLPHENIDATE

03 4APO-METHYLPHENIDATE ER

04 1APO-METHYLPHENIDATE SR

05 8BIPHENTIN

06 4CONCERTA

07 7FOQUEST

08 4PMS-METHYLPHENIDATE

09 8PMS-METHYLPHENIDATE CR

10 4PMS-METHYLPHENIDATE ER

11 1PMS-METHYLPHENIDATE TABLETS 10MG

12 1PMS-METHYLPHENIDATE TABLETS 20MG

13 3QUILLIVANT ER CHEWABLE TABLETS

Veranova Methylphenidate Hydrochloride

List of Suppliers

Product Main Page

01

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 10MG

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

02

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 20MG

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

03

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 18MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 27MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 36MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

Pharmascience Inc.

Compamed

Not Confirmed

Pharmascience Inc.

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 54MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

PHARMASCIENCE INC

Compamed

Not Confirmed

PHARMASCIENCE INC

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number : 584991

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

09

PHARMASCIENCE INC

Compamed

Not Confirmed

PHARMASCIENCE INC

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number : 585009

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

10

PHARMASCIENCE INC

Compamed

Not Confirmed

PHARMASCIENCE INC

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number : 2234749

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?